{
    "summary": "The PREP Repeal Act aims to remove liability shields for pharmaceutical manufacturers related to public health emergencies. It repeals sections 319F-3 and 319F-4 of the Public Health Service Act, which granted these immunities, and rescinds the unobligated balances in the Covered Countermeasure Process Fund. The bill also clarifies that it does not limit existing rights to seek civil remedies for harm. The Act applies to pending actions and those commenced after its enactment, and includes a severability clause.",
    "tags": [
        "Healthcare",
        "Public safety",
        "Consumer protection",
        "COVID-19 response",
        "Legal immunity",
        "Healthcare access",
        "Transparency"
    ],
    "category": "Healthcare & Public Health"
}